Neuroscientific Biopharmaceuticals Ltd has released a press release.
Quarterly Activities/Appendix 4C Cash Flow Report
Earlier from Neuroscientific Biopharmaceuticals
- Successful Clinical Results Achieved under Special Access
- Trading Halt
- Fourth Patient Commences StemSmart MSC Treatment
- 2025 Annual Report & Appendix 4E